Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-29

Clinical Trial Update: Apixaban for the Acute Treatment of Venous Thromboembolism in Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results assess the safety and efficacy of apixaban for acute treatment of venous thromboembolism in children; the study has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Venous Thromboembolism | Phase 4 | Status: COMPLETED | Results posted: 2024-10-29